Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1575351 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Condition: Paralysis
Intervention: Drug: neostigmine

Indicates status has not been verified in more than two years